Artículo Especial
Malnutrition, pharmaconutrition and other considerations in AL amiloidosis, a rare disease with masquerading symptoms and usually delayed diagnosis
Número de descargas:
4130
Número de visitas:
947
Compártelo:
Amyloid Light-chain (AL) amyloidosis is a very rare disease. Nutritional and pharmaconutrional aspects are described. Nutrition repletion of malnourished AL patients is an essential strategy for improving treatment efficacy and clinical outcomes. Early diagnosis of AL amiloidosis is difficult to establish due to the fact that signs and symptoms appearing mimic other processes that delay the final correct histological diagnosis. Untreated patients with this disease have a dismal outcome, with a median survival of 10-14 months from diagnosis. The sooner the treatment is established the better the results are. Modern chemotherapeutical agents, based primarily in cyclophosphamide, bortethomid and dexametasone, produce a rapid, deep, and durable response in the majority of patients. Autologous stem cell transplantation remains restricted to selected patients who are generally without advanced cardiac amyloidosis.
Palabras Clave: AL amyloidosis. Cardiac amyloidosis.
Artículos más populares
Trabajo Original: Effect of dietary chia supplementation on glucose metabolism and adipose tissue function markers in non-alcoholic fatty liver disease subjects
Background: adipose tissue dysfunction is a key fa...
Trabajo Original: Relación entre la condición física y síntomas depresivos en universitarios: un análisis transversal
Objetivo: la condición física es uno de los factor...
-
Licencia creative commons: Open Access bajo la licencia Creative Commons 4.4 CC BY-NC-SA
https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode
